BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9569027)

  • 1. Stable reintroduction of wild-type P53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells.
    Lang D; Miknyoczki SJ; Huang L; Ruggeri BA
    Oncogene; 1998 Mar; 16(12):1593-602. PubMed ID: 9569027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable expression of temperature-sensitive p53: a suitable model to study wild-type p53 function in pancreatic carcinoma cells.
    Nuevemann D; Christgen M; Ungefroren H; Kalthoff H
    Oncol Rep; 2006 Sep; 16(3):575-9. PubMed ID: 16865258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
    Moretti F; Farsetti A; Soddu S; Misiti S; Crescenzi M; Filetti S; Andreoli M; Sacchi A; Pontecorvi A
    Oncogene; 1997 Feb; 14(6):729-40. PubMed ID: 9038381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.
    Tamura T; Aoyama N; Saya H; Haga H; Futami S; Miyamoto M; Koh T; Ariyasu T; Tachi M; Kasuga M
    Oncogene; 1995 Nov; 11(10):1939-46. PubMed ID: 7478511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
    Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cells.
    Cascalló M; Mercadé E; Capellà G; Lluís F; Fillat C; Gómez-Foix AM; Mazo A
    Cancer Gene Ther; 1999; 6(5):428-36. PubMed ID: 10505853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of adenovirus-mediated wild-type p53 expression on the growth of human pancreatic carcinoma cell line cells].
    Guo H; Liu T; Gao J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Oct; 20(5):345-50. PubMed ID: 11717990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells.
    Kremenetskaya OS; Logacheva NP; Baryshnikov AY; Chumakov PM; Kopnin BP
    Oncol Res; 1997; 9(4):155-66. PubMed ID: 9268986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.
    Kusumoto M; Ogawa T; Mizumoto K; Ueno H; Niiyama H; Sato N; Nakamura M; Tanaka M
    Clin Cancer Res; 1999 Aug; 5(8):2140-7. PubMed ID: 10473098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small cell lung carcinoma.
    Adachi J; Ookawa K; Shiseki M; Okazaki T; Tsuchida S; Morishita K; Yokota J
    Cell Growth Differ; 1996 Jul; 7(7):879-86. PubMed ID: 8809405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells.
    Friedman SL; Shaulian E; Littlewood T; Resnitzky D; Oren M
    Oncogene; 1997 Jul; 15(1):63-70. PubMed ID: 9233778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism.
    Hori M; Suzuki K; Udono MU; Yamauchi M; Mine M; Watanabe M; Kondo S; Hozumi Y
    Arch Dermatol Res; 2009 Oct; 301(9):631-46. PubMed ID: 19009304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells.
    Ling YH; Zou Y; Perez-Soler R
    Anticancer Res; 2000; 20(2A):693-702. PubMed ID: 10810342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
    Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
    Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine.
    Sugikawa E; Hosoi T; Yazaki N; Gamanuma M; Nakanishi N; Ohashi M
    Anticancer Res; 1999; 19(4B):3099-108. PubMed ID: 10652599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.